Gemini Gets Green Light for Prediction Markets in the US
Gemini receives CFTC license to launch prediction markets for US customers.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Gemini receives CFTC license to launch prediction markets for US customers.
Oracle stock drops 11% after missing revenue targets despite massive AI investments. Cloud sales lag expectations while capital spending jumps to $50B, raising investor concerns about AI profitability timeline.
Adobe surpasses Q4 estimates with $6.19B revenue and projects FY2026 revenue up to $26.1B, driven by strong AI tool adoption and double-digit ARR growth targets.
Jefferies raises Olema Oncology’s price target to $43 as new Roche giredestrant data strengthens confidence in next-generation SERDs and multibillion-dollar market potential.
Hims shares fell after lawmakers proposed the SAFE Drugs Act, a bill that would restrict compounded versions of popular GLP-1 weight-loss drugs. Analysts say the bill could significantly impact Hims’ fastest-growing product category.
GOP lawmakers explore site-neutral Medicare payments for hospitals as they search for alternatives to extending expiring Affordable Care Act subsidies affecting 20+ million Americans.